Results 1 to 10 of about 18,563 (231)

Pseudomyxoma peritonei [PDF]

World Journal of Gastrointestinal Oncology, 2010
Pseudomyxoma peritonei (PMP) is an uncommon "borderline malignancy" generally arising from a perforated appendiceal epithelial tumour. Optimal treatment involves a combination of cytoreductive surgery (CRS) with heated intraperitoneal chemotherapy (HIPEC). Controversy persists regarding the pathological classification and its prognostic value. Computed
Katharine E, Bevan, Faheez, Mohamed, Brendan J, Moran   +2 more
  +8 more sources

Efficacy and safety in the use of intraperitoneal hyperthermia chemotherapy and peritoneal cytoreductive surgery for pseudomyxoma peritonei from appendiceal neoplasm: A systematic review [PDF]

, 2022
The objective of this systematic review is to provide efficacy and safety data in the application of Intra-Abdominal Hyperthermia Chemotherapy (HIPEC) and Cytoreductive Surgery (CRS) in patients with Peritoneal Pseudomyxoma (PMP) of origin in the cecal ...
Bernardo, Wanderley Marques, Cafalli, Claudia, Floriano, Idevaldo, Reis, João C., Silvinato, Antônio   +4 more
core   +3 more sources

Stemness and hybrid epithelial‐mesenchymal profiles guide peritoneal dissemination of malignant mesothelioma and pseudomyxoma peritonei [PDF]

International Journal of Cancer, Volume 156, Issue 1, Page 201-215, 1 January 2025.
What's new? Factors involved in peritoneal dissemination of malignant mesothelioma (MM) and pseudomyxoma peritonei (PMP) are poorly characterized. Increased amounts of cancer stem cells identified high‐grade PMP and distinguished mass‐derived from ascitic/mucin‐associated cells in MM and PMP.
Nayana Lazzari, Giulia Rigotto, Barbara Montini, Paola Del Bianco, Elena Moretto, Federica Palladino, Rocco Cappellesso, Marco Tonello, Carola Cenzi, Antonio Scapinello, Maria Assunta Piano, Carlo Riccardo Rossi, Piero Dalerba, Pierluigi Pilati, Antonio Sommariva, Maria Luisa Calabrò   +15 more
openalex   +2 more sources

Surveillance of low-grade appendiceal mucinous neoplasms for progression to pseudomyxoma peritonei: Results from a structured surveillance programme. [PDF]

Colorectal Dis
Abstract Aim Low‐grade appendiceal mucinous neoplasm (LAMN) of the appendix is a rare tumour that can progress to pseudomyxoma peritonei (PMP). There is a lack of standardization of surveillance following resection of LAMN as the progression rate to PMP is unclear.
Hannan E, Roman LM, O'Brien L, Mueller A, Staunton O, Shields C, Aird J, Mulsow J.   +7 more
europepmc   +2 more sources

Pseudomyxoma peritonei [PDF]

Postgraduate Medical Journal, 2002
Abstract Pseudomyxoma peritonei is a relatively rare and poorly understood condition in which mucus accumulates within the peritoneal cavity. The presence of cells in the mucin, either inflammatory or neoplastic, distinguishes it from simple acellular mucus ascites caused by mucinous spillage.
S, Jivan, V, Bahal
  +6 more sources

Pseudomyxoma peritonei [PDF]

Journal of British Surgery, 1998
Abstract Background Pseudomyxoma peritonei is an unusual condition in which gelatinous fluid collections are associated with mucinous implants on the peritoneal surfaces and omentum. The pathological origin and ideal treatment of the condition are subjects of debate.
F L, Hinson, N S, Ambrose
  +7 more sources

Pseudomyxoma Peritonei [PDF]

Klinicka Onkologie, 2019
Pseudomyxoma peritonei is a rare tumorous disease with various grades of malignancy and is characterized by production of mucinous and gelatinous masses. Development of pseudomyxoma peritonei is usually associated with rupture of appendiceal mucinous tumors and other mucinous tumors of the gastrointestinal tract or ovaries.
Petr, Bartoška, František, Antoš, Pavel, Vítek, Josef, Marx, Jiří, Kopic, Petra, Holečková   +5 more
openaire   +2 more sources

The Delphi and GRADE methodology used in the PSOGI 2018 consensus statement on Pseudomyxoma Peritonei and Peritoneal Mesothelioma

, 2021
Pseudomyxoma Peritonei (PMP) and Peritoneal Mesothelioma (PM) are both rare peritoneal malignancies. Currently, affected patients may be treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy offering long-term survival or even ...
de Hingh, I.,, Deraco, M.,, Glehen, O.,, Govaerts, K.,, Kepenekian, V.,, Kusamura, S.,, Lund University., Lurvink, R.J,, Moran, B.,, PSOGI, Syk, Ingvar,, Van der Speeten, K.,, Villeneuve, L.,   +12 more
core   +1 more source

Pseudomyxoma Peritonei [PDF]

Journal of the Royal Society of Medicine, 1986
In pseudomyxoma peritonei, mucinous implants develop on peritoneal surfaces and omentum, often resulting in gelatinous ascites. Definitive treatment has not been established. Adjunctive radiation therapy or chemotherapy following laparotomy has improved survival in some patients.
J S, Friedland, J T, Allardice, A P, Wyatt   +2 more
openaire   +4 more sources

Pseudomyxoma peritonei

BJOG: An International Journal of Obstetrics & Gynaecology, 1996
Pseudomyxoma peritonei is a clinical entity that has lead to much confusion about its etiology, clinical manifestations, treatment, and prognosis. Pseudomyxoma peritonei is currently defined as a grade I mucinous adenocarcinoma that arises from a primary appendiceal adenoma. The clinical entity is defined by a redistribution phenomenon. This means that
K, GEORGIEV, K, SERAFIMOV
  +7 more sources